Last reviewed · How we verify

NCT03930511: SmartReab

Telemonitoring Physical Activity in Daily Life on Chronic Respiratory Patients

Completed NA Last updated 10 November 2020
What this trial tests

NA trial testing Pulmonary Rehabilitation in Chronic Respiratory Disease in 100 participants. Completed in 30 October 2019.

Timeline
18 January 2017
Primary endpoint
31 October 2018
30 October 2019

Quick facts

Lead sponsorUniversity of Lisbon
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment100
Start date18 January 2017
Primary completion31 October 2018
Estimated completion30 October 2019
Sites2 locations across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

University of Lisbon

Who can join

Eligibility, any sex, with Chronic Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Physical inactivity is a consequence of chronic diseases and on Chronic Obstructive Pulmonary Disease patients is an independent predictor of the risk of hospitalizations and early mortality. As physical inactivity is a modifiable risk factor with healthy lifestyle interventions, health professionals should clinically assess physical activity as a vital sign of patients' general physical condition. SmartReab study aims to characterize physical activity in daily life of 100 chronic respiratory patients at baseline when starting Pulmonary Rehabilitation, at discharge time of the program, at 6 months and 1 year follow-up. The Pulmonary Rehabilitation program will be individually tailored according to patients needs and goals settled within the Rehabilitation team and it will take place at Hospital Pulido Valente, from Centro Hospitalar Universitário Lisboa Norte, in Lisbon, Portugal. To access physical activity in daily life patients will participate in a telemonitoring study for 4 days using a smartphone and an oximeter and also answer to the International Physical Activity Questionnaire. SmartReab technology will provide data of physical activity intensity, heart rate and oxygen levels during awakening periods of daytime. To associate physical activity with other aspects related with health and the impact of Pulmonary Rehabilitation, patients will also take a 6 minute walk test and answer questionnaires related with self-perceived health status, impact of respiratory symptoms on quality of life, dyspnea impact on general mobility and on daily life situations, and also anxiety and depression feelings. The research hypothesis is that Pulmonary Rehabilitation will have a positive impact on physical activity in the short, medium and long terms.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Telemonitoring of daily activities compared to the six-minute walk test further completes the puzzle of oximetry-guided interventions.
    Santos CD, Santos AF, das Neves RC, Ribeiro RM, et al · · 2021 · cited 10× · PMID 34400715 · DOI 10.1038/s41598-021-96060-w
  2. Novel Input for Designing Patient-Tailored Pulmonary Rehabilitation: Telemonitoring Physical Activity as a Vital Sign-SMARTREAB Study.
    Santos CD, das Neves RC, Ribeiro RM, Caneiras C, et al · · 2020 · cited 5× · PMID 32751825 · DOI 10.3390/jcm9082450

Verify or expand the search:

Other trials of Pulmonary Rehabilitation

Trials testing the same drug.

Other recruiting trials for Chronic Respiratory Disease

Currently open trials in the same condition.

Other University of Lisbon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03930511.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing